Kati Richter

Kati Richter is a postdoctoral researcher at the University of Oulu's Faculty of Biochemistry and Molecular Medicine. Her key affiliations include:

• ECM and Hypoxia research unit
• Gene Cell Nano Flagship program

Her research focuses on vascular and neurodegenerative eye diseases, aiming to identify signaling pathways and target molecules for new treatment strategies. This work integrates biochemistry, cell biology, and molecular biology to investigate disease mechanisms related to extracellular matrix (ECM) and hypoxia, with direct applications in ophthalmology.

Dr. Richter holds a PhD degree and actively contributes to the Gene Cell Nano Flagship program, which advances interdisciplinary research in gene therapy, cell biology, and nanotechnology for biomedical applications. Her laboratory work centers on cellular responses to hypoxic conditions and ECM alterations in ocular pathologies.